Table 4.
Post-discharge 1-month clinical outcomes. SBP, systolic blood pressure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction.
| Total | Inotrope Users | Inotrope Non-Users | p Value | |
|---|---|---|---|---|
| 1-month mortality | 176/5213 (3.4%) | 81/1483 (5.5%) | 95/3730 (2.5%) | <0.001 |
| Subgroup—by initial SBP | ||||
| Low Initial SBP | 20/244 (8.2%) | 14/157 (8.9%) | 6/87 (6.9%) | 0.582 |
| Normal Initial SBP | 156/4941 (3.2%) | 67/1309 (5.1%) | 89/3632 (2.5%) | <0.001 |
| Subgroup—by LV systolic function | ||||
| HFrEF | 114/3037 (3.8%) | 61/1024 (6.0%) | 53/2013 (2.6%) | <0.001 |
| HRmrEF | 17/727 (2.3%) | 5/163 (3.1%) | 12/564 (2.1%) | 0.484 |
| HFpEF | 37/1245 (3.0%) | 9/237 (3.8%) | 28/1008 (2.8%) | 0.406 |